Literature DB >> 25832970

Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.

Nandita Kachru1, Ryan M Carnahan, Michael L Johnson, Rajender R Aparasu.   

Abstract

BACKGROUND: Inappropriate medications are often used in older adults despite their unfavourable risk-to-benefit profile. Although many of the medications in the American Geriatrics Society (AGS) Beers list are potentially inappropriate because of their anticholinergic properties, little is known regarding the nature and extent of potentially inappropriate anticholinergic medication use in older adults.
OBJECTIVES: To determine the prevalence of, and factors associated with, potentially inappropriate anticholinergic medication use in the older population.
METHODS: A retrospective, cross-sectional study was conducted, involving older adults (aged 65 years and older), using 2009-2010 Medical Expenditure Panel Survey (MEPS) data. The 2012 AGS Beers Criteria were used to define potentially inappropriate anticholinergic medications on the basis of the list of medications to avoid using in older adults irrespective of the diagnosis. Descriptive analyses were used to examine the nature and extent of potentially inappropriate anticholinergic medication use. Multivariable logistic regression within the conceptual framework of the Andersen Behavioral Model was used to identify the factors associated with potentially inappropriate anticholinergic use in older adults.
RESULTS: According to the MEPS, there were 78.60 million older adults in the USA; an estimated 7.51 million (9.56 %) of these older adults used potentially inappropriate anticholinergic medications in 2009-2010. The most frequently used potentially inappropriate anticholinergics were cyclobenzaprine, promethazine, amitriptyline, hydroxyzine and dicyclomine. Multivariable regression analyses revealed that female sex, residing in the South and the presence of anxiety disorder increased the likelihood of receiving potentially inappropriate anticholinergic medications, whereas older adults aged 75-84 or ≥ 85 years, and those with over 15 years of education, had a decreased likelihood of receiving potentially inappropriate anticholinergic medications.
CONCLUSION: The study found that approximately one in ten older adults used potentially inappropriate anticholinergic medications. Several predisposing, enabling and need factors were associated with the use of potentially inappropriate anticholinergic medications. Concerted efforts are needed to optimize potentially inappropriate anticholinergic medication use in older adults.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832970     DOI: 10.1007/s40266-015-0257-x

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  40 in total

Review 1.  Assessing medication appropriateness in the elderly: a review of available measures.

Authors:  P S Shelton; M A Fritsch; M A Scott
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium.

Authors:  L Tune; S Carr; E Hoag; T Cooper
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

3.  Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study.

Authors:  Eeva-Katri Kumpula; J Simon Bell; Helena Soini; Kaisu H Pitkälä
Journal:  J Clin Pharmacol       Date:  2010-05-20       Impact factor: 3.126

4.  Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.

Authors:  Irene Seunghyun Hong; Jeffrey R Bishop
Journal:  Ann Pharmacother       Date:  2010-06-29       Impact factor: 3.154

5.  Evaluation of the quality of drug therapy among elderly patients in nursing homes.

Authors:  Asa Bergman; Jonny Olsson; Anders Carlsten; Margda Waern; Johan Fastbom
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

Review 6.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

7.  Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.

Authors:  Rituparna Bhattacharya; Satabdi Chatterjee; Ryan M Carnahan; Rajender R Aparasu
Journal:  Am J Geriatr Pharmacother       Date:  2011-10-26

8.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

9.  The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?

Authors:  Ryan M Carnahan; Brian C Lund; Paul J Perry; Elizabeth A Chrischilles
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

10.  Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.

Authors:  Alex Z Fu; Jenny Z Jiang; Jaxk H Reeves; Jack E Fincham; Gordon G Liu; Matthew Perri
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

View more
  17 in total

1.  Factors associated with potentially inappropriate medication use in community-dwelling older adults in the United States: a systematic review.

Authors:  Stephanie K Nothelle; Ritu Sharma; Allison Oakes; Madeline Jackson; Jodi B Segal
Journal:  Int J Pharm Pract       Date:  2019-04-09

2.  Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.

Authors:  Laurine Andre; Adeline Gallini; François Montastruc; Jean-Louis Montastruc; Antoine Piau; Maryse Lapeyre-Mestre; Virginie Gardette
Journal:  Eur J Clin Pharmacol       Date:  2019-08-29       Impact factor: 2.953

3.  Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.

Authors:  Shelly L Gray; Melissa L Anderson; Joseph T Hanlon; Sascha Dublin; Rod L Walker; Rebecca A Hubbard; Onchee Yu; Thomas J Montine; Paul K Crane; Josh A Sonnen; C Dirk Keene; Eric B Larson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  The Association between Anticholinergic Drug Use and Rehabilitation Outcome in Post-Acute Hip Fractured Patients: A Retrospective Cohort Study.

Authors:  Avital Hershkovitz; Corina Angel; Shai Brill; Ran Nissan
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

5.  Potential Targets for Deprescribing in Medically Complex Older Adults with Suspected Cognitive Impairment.

Authors:  Juliessa M Pavon; Theodore S Z Berkowitz; Valerie A Smith; Jaime M Hughes; Anna Hung; Susan N Hastings
Journal:  Geriatrics (Basel)       Date:  2022-05-19

6.  Anticholinergic medication and dental caries status in middle-aged xerostomia patients-a retrospective study.

Authors:  Mayank Kakkar; Abdul Basir Barmak; Szilvia Arany
Journal:  J Dent Sci       Date:  2021-12-29       Impact factor: 3.719

7.  Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.

Authors:  Joshua Niznik; Xinhua Zhao; Tao Jiang; Joseph T Hanlon; Sherrie L Aspinall; Joshua Thorpe; Carolyn Thorpe
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

8.  National Prescribing Trends for High-Risk Anticholinergic Medications in Older Adults.

Authors:  Taeho Greg Rhee; Yookyung Christy Choi; Gregory M Ouellet; Joseph S Ross
Journal:  J Am Geriatr Soc       Date:  2018-03-26       Impact factor: 5.562

9.  Decrease of Anticholinergic Drug Use in Nursing Home Residents in the United States, 2009 to 2017.

Authors:  Ioannis Malagaris; Hemalkumar B Mehta; Shuang Li; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2020-08-15       Impact factor: 5.562

10.  Cluster analysis of multiple chronic conditions associated with urinary incontinence among women in the USA.

Authors:  Alayne D Markland; Camille P Vaughan; Ike S Okosun; Patricia S Goode; Kathryn L Burgio; Theodore M Johnson
Journal:  BJU Int       Date:  2018-05-09       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.